SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, has ...

SAN FRANCISCO - The Pac-12 Conference announced today that it has entered into an agreement with diagnostic test leader Quidel Corporation to implement up to daily testing for COVID-19 with ...

WASHINGTON (AP) Â Speed and accuracy are key features when screening for coronavirus. Quidel Corp. is one of a handful of U.S. companies authorized to sell a rapid test for COVID-19, yielding results ...

Quidel Corporation QDEL has been gaining on the back of its strong diagnostics portfolio. A solid third-quarter 2021 performance, along with solid potential in In-Vitro Diagnostics (“IVD”) products, ...

The FDA’s emergency use authorization (EUA) program for rapid antigen tests for the COVID-19 pandemic is coming to an end, but few rapid antigen test makers have laid out clear plans regarding the ...

Quidel Corporation QDEL is scheduled to report first-quarter 2022 results on May 4, after the closing bell. In the last-reported quarter, the company’s earnings of $7.29 per share surpassed the Zacks ...

Quidel's Q4 revenue and earnings dropped sharply from the prior-year period. However, the company's results topped consensus estimates. Quidel's future growth drivers include the U.S. launch of a new ...

It takes money to make money. Most investors know that, but with business media so focused on the "how much," very few investors bother to ask, "How fast?" Let's break this down In this series, we ...

(Reuters) - The U.S. Food and Drug Administration (FDA) on Saturday approved emergency use authorization (EUA) to Quidel Corp for the first COVID-19 antigen test. The emergency use authorization was ...